Betty Gilpin has three Emmy nominations for GLOW, an Emmy of her own and a supporting part in Aaron Sorkin’s The Social Reckoning that reviewers keep singling out. She still told The New Yorker that she had never done Broadway because she “just straight up was-slash-am not famous enough.” The line landed as self-deprecation. It is also the clearest description of how Broadway hires now, offered by an actress the system has already priced.

MCM reads the remark as a diagnosis, not a grievance, and agrees with it. Broadway has turned into a game for movie stars because the money leaves producers little room to play anything else. Gilpin’s own debut shows where the game still leaves a door open: inside a hit that is already its own star. Oh, Mary! did not need her fame. It lent her its own for eight weeks, then went back to selling famous names. That borrowed spotlight is the last cheap way onto Broadway for actors like her, and the hit that offered it to her has spent the time since filling the same seat with bigger names.

What Betty Gilpin told The New Yorker about Broadway

The interview, which BroadwayWorld’s Michael Gioia summarized the day after The New Yorker published it, returns to her Broadway debut as Mary Todd Lincoln in Oh, Mary!, the comedy Cole Escola wrote and originated. Gilpin was the first actor to take the role after Escola. Asked about the state of Broadway, she called it “a game for movie stars,” and gave the producers’ side of it in the same breath: “they have to support a commercial run and get butts in seats.”

By her account, the call came while she was in Budapest shooting Death by Lightning, in which she plays Lucretia Garfield. Escola had seen her private Instagram videos and thought she might be “demented enough” for Mary Todd. BroadwayWorld reports that she compared the short rehearsal period to rehearsing Gladiator in a Starbucks. “Going out onstage that first time was the most afraid I’ve ever been,” she said. “It was a wild eight weeks.”

This matters beyond one actress’s anecdote. If a performer with Gilpin’s record calls herself too obscure for a Broadway lead, the threshold for getting one is no longer craft or even television success. It is a level of fame most working actors will never reach, and that threshold decides which plays get produced, how long they run and what a ticket buyer is offered on any given night.

Broadway’s star game, in numbers

The economics behind her line are public. In a report for ABC7 New York, Julie James, program director of SiriusXM On Broadway, said the cost of producing a Broadway musical “has roughly doubled over the past decade,” that an average musical can cost more than $20 million to mount and that weekly running costs approach $1 million. Her starkest example: a show that takes in $1 million a week at 94% capacity has “only broke even.”

Drew Shade, founder of Broadway Black, put the consequence in one sentence for the same report: “The shows that have sold have included celebrities.” ABC7 added that only six original musicals opened on Broadway last season, down from roughly 15 two seasons earlier. When almost every risk is expensive, a famous name stops being a luxury and becomes insurance.

The insurance does not always pay. Writing for BroadwayWorld, Ben Waterhouse described the logic of the star-led limited run: stars “have busy schedules,” committing to “16 or 20 weeks” is a juggling act, and the short engagement is meant to “increase demand by creating artificial scarcity.” He also argued that it is “nigh-on impossible” to earn back a full musical capitalization in a run that short, and pointed to The Last Five Years with Nick Jonas, which “closed at a significant loss.” The star system is not a formula for profit. It is a hedge against the fear of empty seats.

How Oh, Mary! cast an actress who was ‘not famous enough’

Oh, Mary! could hire Gilpin on talent because the show itself had become the attraction. Escola’s comedy arrived with its own reputation, and audiences were buying the title and the joke as much as any name above it. That gave the production a freedom most new shows do not have: it could cast the replacement who fit the part rather than the one who would move the most tickets on her own, and, by Gilpin’s account, it found her through phone videos rather than a box-office chart.

Broadway did not discover Betty Gilpin. A hit lent her its fame for eight weeks. That is a narrower door than the one Broadway once had, when a play could build an actor’s name over a long run, but it is still a door, and it opens only in shows strong enough not to need a star in the lead.

Look at what the same seat has carried since. Later Marys have included Jinkx Monsoon, Jane Krakowski and Maya Rudolph, the Saturday Night Live alumna, whose run Playbill reported made Oh, Mary! the first show in the Lyceum Theatre’s 121-year history to gross more than $1 million in a single week. Her engagement was extended, and Meg Stalter followed her. The replacement slot that once went to a television actress who felt under-famous became the slot that set the theatre’s box-office record.

The case for the movie-star game

Producers would answer that Gilpin is describing the thing that keeps Broadway open. A star’s name sells to people who do not usually buy theatre tickets, and those buyers pay for everyone else on the payroll. Rudolph’s record week did not only flatter Rudolph; it helped carry a production that now sells seats into January 2027, which means more months of work for a cast and crew whose names nobody reads in the headlines. Shade’s line is the bluntest form of the argument, and the numbers James gave ABC7 back it up.

There is a fairness argument too. With costs doubled and break-even sitting close to a full house, a producer who casts purely on craft is gambling investors’ money on taste. Waterhouse concedes that stars make sense for limited runs because their schedules allow nothing longer. And Gilpin herself grants the premise: shows “have to support a commercial run.” Read this way, Broadway is not snubbing actors like her; it is surviving, and the occasional replacement slot is a bonus the system can afford only because the stars pay for it.

Why the replacement slot matters more than the stars

That defense is right about each individual show and wrong about the system. Waterhouse’s own example shows that a famous lead does not guarantee recoupment, and ABC7’s count of original musicals shows what the hedge costs: fewer new works, because new works carry no brand and rarely carry a star. A theatre economy built on famous names produces more famous names in fewer new plays.

The casualty is the middle tier: actors with craft and partial fame, the television ensemble player or the stage regular who has never had a hit with her name above the title. Under today’s math, Gilpin reached Broadway only because a long-running success needed a replacement. Those replacement slots are now the place where the stage still hires for talent, precisely because the show handles the marketing. When each new Mary is chosen to beat the last one’s grosses, that last door narrows.

The same pattern follows her on screen. Reviewing The Social Reckoning for The AU Review, Peter Gray wrote that Gilpin “threatens to walk away with the film whenever she’s allowed into it,” while noting that her Wall Street Journal bureau chief has “considerably less screen time” than the leads. Critics praise her in the supporting column; the business keeps betting on fame for the top line. Her Emmy poem, as reported by the Associated Press, said it in her own register: “our business is stupid, but actors are the bomb,” followed by a plea to “lean more toward Sam Shepard and less toward Sam Altman.” Shepard was a playwright. MCM reads the line as an argument for the stage’s scale of value, the actor and the script, over the logic of whatever sells at volume.

On the record, and what MCM reads into it

The record: The New Yorker published its interview with Gilpin on Sunday, October 11, 2026, and BroadwayWorld reported it on October 12, including the “game for movie stars” and “not famous enough” quotes. Her run as Mary Todd Lincoln was an eight-week engagement at the Lyceum Theatre from January 21 to March 16, 2025. Playbill reported Rudolph’s Lyceum record on May 7, 2026; the show sells tickets through January 3, 2027. ABC7’s figures come from a July 2026 report, Waterhouse’s analysis from December 2025, and Gilpin’s Emmy for Widow’s Bay, awarded on September 6, 2026, from the Associated Press.

The interpretation is ours. That Oh, Mary! lent Gilpin its fame, that replacement slots in long-running hits are the last door for actors without star billing, and that the role has since moved toward bigger box-office names are MCM’s reading of public facts. None of Gilpin, Escola or the producers has described the casting that way, and nothing in the record suggests Gilpin was chosen over a more famous candidate.

Gilpin calls herself not famous enough for Broadway, and by the industry’s math she is right. For eight weeks at the Lyceum, though, the show was famous enough for both of them. Broadway should protect that seat as deliberately as it chases stars, because it is the one place left where the stage still casts the actor before the name.

Tags: Betty Gilpin, Cole Escola, Broadway, OH, MARY!, Maya Rudolph, Broadway shows